Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage*
Conclusions:
DDAVP was associated with a decreased likelihood of intracranial hemorrhage expansion during the first 24 hours. DDAVP administration did not significantly affect serum sodium and thrombotic events during the study period.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Neurologic Critical Care Source Type: research
More News: Academia | Bed Wetting | Brain | CT Scan | Emergency Medicine | Enuresis | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Neurosurgery | PET Scan | Sodium | Stroke | Study